-
Je něco špatně v tomto záznamu ?
Longitudinal MRI and neuropsychological assessment of patients with clinically isolated syndrome
T. Uher, J. Blahova-Dusankova, D. Horakova, N. Bergsland, M. Tyblova, RH. Benedict, T. Kalincik, DP. Ramasamy, Z. Seidl, J. Hagermeier, M. Vaneckova, J. Krasensky, E. Havrdova, R. Zivadinov,
Jazyk angličtina Země Německo
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NT13237
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Zdroj
NLK
ProQuest Central
od 1997-04-01 do 2017-12-31
Medline Complete (EBSCOhost)
od 2000-01-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 1997-04-01 do 2017-12-31
- MeSH
- demyelinizační nemoci farmakoterapie imunologie patologie psychologie MeSH
- dospělí MeSH
- interferon beta 1a MeSH
- interferon beta aplikace a dávkování farmakologie MeSH
- kognice účinky léků MeSH
- kognitivní dysfunkce farmakoterapie imunologie patologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- magnetická rezonanční tomografie * MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mozek patologie MeSH
- následné studie MeSH
- neuropsychologické testy MeSH
- progrese nemoci MeSH
- prospektivní studie MeSH
- roztroušená skleróza farmakoterapie imunologie patologie psychologie MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Cognitive impairment (CI) may occur in clinically isolated syndrome (CIS) patients. While the relationship between CI and magnetic resonance imaging (MRI) has been investigated extensively in multiple sclerosis (MS), MRI correlates of CI in CIS patients are unknown. To investigate the evolution of CI and to determine brain MRI structural correlates associated with CI in CIS patients. This prospective 24-month observational study examined 81 CIS patients treated with 30 µg of intramuscular interferon beta 1a once a week. MRI acquisition and neuropsychological (NP) assessment were performed at baseline, 6, 12 and 24 months. Participants were tested with Czech-validated version of Minimal Assessment of Cognitive Function in MS battery and MRI measures of lesion activity and burden, and global, tissue-specific and regional brain atrophy were performed. Over 24 months, 36 CIS patients developed clinically definite MS (CDMS). CI was observed in 10 (12.3 %) CIS patients at baseline and at the 24 months follow-up. Eight CIS patients changed their CI status over the follow-up (four improved and four worsened). No significant difference in development of CI was detected between stable CIS patients and those who developed CDMS. In multivariate regression and mixed-effect model analyses, no significant relationship was found between NP and MRI parameters. The lack of significant relationship between MRI metrics and cognition in this group of CIS patients could be attributed to several factors including the cognitive reserve, effect of disease-modifying therapy and relatively short follow-up period.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16000722
- 003
- CZ-PrNML
- 005
- 20200120154355.0
- 007
- ta
- 008
- 160108s2014 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00415-014-7413-9 $2 doi
- 035 __
- $a (PubMed)24952618
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Uher, Tomáš $u Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine and General University Hospital, Charles University in Prague, Prague, Czech Republic. $7 xx0189534
- 245 10
- $a Longitudinal MRI and neuropsychological assessment of patients with clinically isolated syndrome / $c T. Uher, J. Blahova-Dusankova, D. Horakova, N. Bergsland, M. Tyblova, RH. Benedict, T. Kalincik, DP. Ramasamy, Z. Seidl, J. Hagermeier, M. Vaneckova, J. Krasensky, E. Havrdova, R. Zivadinov,
- 520 9_
- $a Cognitive impairment (CI) may occur in clinically isolated syndrome (CIS) patients. While the relationship between CI and magnetic resonance imaging (MRI) has been investigated extensively in multiple sclerosis (MS), MRI correlates of CI in CIS patients are unknown. To investigate the evolution of CI and to determine brain MRI structural correlates associated with CI in CIS patients. This prospective 24-month observational study examined 81 CIS patients treated with 30 µg of intramuscular interferon beta 1a once a week. MRI acquisition and neuropsychological (NP) assessment were performed at baseline, 6, 12 and 24 months. Participants were tested with Czech-validated version of Minimal Assessment of Cognitive Function in MS battery and MRI measures of lesion activity and burden, and global, tissue-specific and regional brain atrophy were performed. Over 24 months, 36 CIS patients developed clinically definite MS (CDMS). CI was observed in 10 (12.3 %) CIS patients at baseline and at the 24 months follow-up. Eight CIS patients changed their CI status over the follow-up (four improved and four worsened). No significant difference in development of CI was detected between stable CIS patients and those who developed CDMS. In multivariate regression and mixed-effect model analyses, no significant relationship was found between NP and MRI parameters. The lack of significant relationship between MRI metrics and cognition in this group of CIS patients could be attributed to several factors including the cognitive reserve, effect of disease-modifying therapy and relatively short follow-up period.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a mozek $x patologie $7 D001921
- 650 _2
- $a kognice $x účinky léků $7 D003071
- 650 _2
- $a demyelinizační nemoci $x farmakoterapie $x imunologie $x patologie $x psychologie $7 D003711
- 650 _2
- $a progrese nemoci $7 D018450
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a následné studie $7 D005500
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a interferon beta 1a $7 D000068556
- 650 _2
- $a interferon beta $x aplikace a dávkování $x farmakologie $7 D016899
- 650 12
- $a magnetická rezonanční tomografie $7 D008279
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a kognitivní dysfunkce $x farmakoterapie $x imunologie $x patologie $7 D060825
- 650 _2
- $a roztroušená skleróza $x farmakoterapie $x imunologie $x patologie $x psychologie $7 D009103
- 650 _2
- $a neuropsychologické testy $7 D009483
- 650 _2
- $a prospektivní studie $7 D011446
- 650 _2
- $a mladý dospělý $7 D055815
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Blahová Dušánková, Jana $7 jx20070410009
- 700 1_
- $a Horáková, Dana $7 xx0076527
- 700 1_
- $a Bergsland, Niels
- 700 1_
- $a Týblová, Michaela $7 xx0121850
- 700 1_
- $a Benedict, Ralph H B
- 700 1_
- $a Kalincik, Tomas
- 700 1_
- $a Ramasamy, Deepa P
- 700 1_
- $a Seidl, Zdeněk, $d 1950- $7 mzk2004258727
- 700 1_
- $a Hagermeier, Jesper
- 700 1_
- $a Vaněčková, Manuela, $d 1973- $7 mzk2007377403
- 700 1_
- $a Krásenský, Jan $7 xx0096156
- 700 1_
- $a Kubala Havrdová, Eva, $d 1955- $7 nlk19990073204
- 700 1_
- $a Zivadinov, Robert
- 773 0_
- $w MED00002835 $t Journal of neurology $x 1432-1459 $g Roč. 261, č. 9 (2014), s. 1735-1744
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/24952618 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20160108 $b ABA008
- 991 __
- $a 20200120154731 $b ABA008
- 999 __
- $a ok $b bmc $g 1103003 $s 924928
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 261 $c 9 $d 1735-1744 $e 20140622 $i 1432-1459 $m Journal of neurology $n J Neurol $x MED00002835
- GRA __
- $a NT13237 $p MZ0
- LZP __
- $a Pubmed-20160108